Skip to main content
MCRB
NASDAQ Life Sciences

Seres Therapeutics' IBD Candidate SER-603 Shows Positive Preclinical Data, Advances Towards IND

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$7.61
Mkt Cap
$73.3M
52W Low
$6.53
52W High
$29.98
52W Position info
17% above low
Off High info
75% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

MCRB sits 17% above its 52-week low of $6.53 on light trading volume (0.3× avg).

Summary

Seres Therapeutics presented positive preclinical data for SER-603, a next-generation live biotherapeutic candidate for Inflammatory Bowel Disease (IBD), at Digestive Disease Week (DDW) 2026. The data highlighted SER-603's rational design targeting microbial functions linked to mucosal healing and GI inflammation, with the presentation earning a 'Poster of Distinction'. This update is significant as the company is advancing SER-603 through IND-enabling activities and engaging potential collaborators for clinical development. This positive pipeline news provides a much-needed boost, especially after the company issued a going concern warning and paused its lead clinical program (SER-155 Phase 2) due to funding issues, as noted in its last 10-K. Traders will be watching for further progress on IND-enabling activities and any potential collaboration agreements that could provide funding and advance SER-603 into human trials.

At the time of this announcement, MCRB was trading at $7.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $73.3M. The 52-week trading range was $6.53 to $29.98. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

MCRB - Latest Insights

MCRB
Nov 04, 2026, 10:00 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.87
Real-time Price: $1.41 info
Change: -$0.460 (-25%) info
Market Cap: $14.375M info
MCRB
Nov 04, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.79
Real-time Price: $1.41 info
Change: -$0.380 (-21%) info
Market Cap: $14.375M info
MCRB
Nov 04, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.74
Real-time Price: $1.41 info
Change: -$0.325 (-19%) info
Market Cap: $14.375M info
MCRB
Oct 26, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.98
Real-time Price: $1.41 info
Change: -$0.570 (-29%) info
Market Cap: $14.375M info
MCRB
Aug 05, 2026, 10:30 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $5.04
Real-time Price: $1.41 info
Change: -$3.63 (-72%) info
Market Cap: $14.375M info